Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 78.65
+0.95 (1.22%)
Aug 7, 2026, 2:50 PM CET
Pharma Mar Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 59.65 | 11.99 | -24.66 | 43.79 | 109.38 |
Depreciation & Amortization | 8.02 | 6.77 | 3.31 | 5.9 | 2.68 |
Stock-Based Compensation | - | - | 0.91 | 0.39 | 0.72 |
Other Adjustments | -4.05 | 6.97 | 33.58 | 15.24 | -5.2 |
Change in Receivables | -4.99 | -7.32 | 10.63 | 21.61 | -34.03 |
Changes in Inventories | -2.13 | -12.68 | -12.14 | -17.21 | 1.5 |
Changes in Accounts Payable | -12.76 | -1.43 | -3.74 | 1.79 | 7.69 |
Changes in Other Operating Activities | 9.39 | 1.73 | -14.49 | -33.19 | -44.55 |
Operating Cash Flow | 53.13 | 6.03 | -6.6 | 38.32 | 38.19 |
Operating Cash Flow Growth | 781.53% | - | - | 0.35% | -86.31% |
Capital Expenditures | -6.46 | -15.02 | -3.5 | -8.85 | -6.27 |
Sale of Property, Plant & Equipment | - | 0.89 | - | 0.01 | - |
Purchases of Intangible Assets | -2.92 | -0.5 | -0.35 | - | -0.25 |
Purchases of Investments | -342.58 | -351.48 | -314.01 | -219.2 | 0 |
Proceeds from Sale of Investments | 286.27 | 367.13 | 287.24 | 238.92 | 25.36 |
Cash Acquisitions | - | - | -27.4 | - | -13.41 |
Other Investing Activities | 4.9 | - | - | - | - |
Investing Cash Flow | -60.79 | 1.03 | -58.02 | 10.88 | 5.44 |
Long-Term Debt Issued | 1.33 | 15.41 | 7.94 | 1.54 | 1.9 |
Long-Term Debt Repaid | -4.7 | -8.62 | -10.01 | -10.2 | -21.75 |
Net Long-Term Debt Issued (Repaid) | -3.37 | 6.79 | -2.07 | -8.66 | -19.84 |
Issuance of Common Stock | 15.87 | 18.84 | 19.46 | 57.23 | 33.56 |
Repurchase of Common Stock | -34.12 | -18.63 | -37.9 | -50.18 | -40.67 |
Net Common Stock Issued (Repurchased) | -18.25 | 0.22 | -18.44 | 7.05 | -7.11 |
Common Dividends Paid | -13.95 | -11.42 | -11.69 | -11.76 | -10.87 |
Other Financing Activities | -0.96 | -0.94 | - | - | - |
Financing Cash Flow | -36.52 | -5.35 | -27.19 | -13.37 | -26.95 |
Foreign Exchange Rate Adjustments | -1.24 | 1.51 | -1.19 | 0.64 | -0.41 |
Net Cash Flow | -45.42 | 3.22 | -93 | 36.47 | 16.27 |
Free Cash Flow | 46.67 | -8.99 | -10.1 | 29.47 | 31.92 |
Free Cash Flow Growth | - | - | - | -7.68% | -88.43% |
FCF Margin | 21.08% | -2.57% | -6.38% | 8.20% | 13.89% |
Free Cash Flow Per Share | 2.67 | -0.51 | -0.56 | 1.63 | 1.76 |
Levered Free Cash Flow | 67.68 | 26.4 | -31.49 | -1.27 | 34.06 |
Unlevered Free Cash Flow | 72.39 | 16.86 | -29.35 | 11.16 | 51.29 |